
Montymo AL 75mg/5mg/10mg Tablet SR
Marketer
Morepen Laboratories Ltd
Salt Composition
Ambroxol (75mg) + Levocetirizine (5mg) + Montelukast (10mg)
Overview Montymo AL 75mg/5mg/10mg Tablet SR
RespiClear 75/5/10mg Extended-Release Tablets combine medications to manage respiratory conditions involving thick mucus. This treatment offers relief from productive coughs related to bronchial asthma, bronchitis, and the common cold. RespiClear 75/5/10mg ER Tablets can be taken with or without food, following your doctor's prescribed dosage and duration. Treatment length depends on your response and condition. Premature discontinuation may cause symptom recurrence and worsening. Inform your healthcare provider of all other medications you're using, as interactions are possible. Common side effects include nausea, indigestion, dry mouth, flu-like symptoms, tiredness, and headache; most are transient. Report any concerning side effects immediately. Drowsiness and dizziness may occur; avoid driving or activities requiring alertness until the effects are known. Alcohol should be avoided due to increased drowsiness risk. Disclose any kidney or liver conditions before starting treatment to ensure appropriate dosage. Also, inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Uses of Montymo AL 75mg/5mg/10mg Tablet SR
Managing respiratory conditions characterized by thick mucus.
Major Benefits of Montymo AL 75mg/5mg/10mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Montymo AL 75mg/5mg/10mg Extended-Release Tablets may be consumed with or without food, though consistent timing is recommended.
Common Side effects of Montymo AL 75mg/5mg/10mg Tablet SR:
- Nausea
- Upset stomach
- Dryness in mouth
- Headache
- Fatigue
- Allergic reaction
- Sleepiness
- Flu-like symptoms
How to use Montymo AL 75mg/5mg/10mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Montymo AL 75mg/5mg/10mg Extended-Release Tablets can be consumed with or without food, although consistent daily timing is recommended.
How Montymo AL 75mg/5mg/10mg Tablet SR works:
Each Montymo AL 75mg/5mg/10mg sustained-release tablet combines ambroxol, levocetirizine, and montelukast to address respiratory symptoms. Ambroxol, a mucolytic agent, facilitates mucus clearance by reducing its viscosity. Levocetirizine, an antihistamine, alleviates allergic rhinitis manifestations such as nasal discharge, lacrimation, and sneezing. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, thereby diminishing airway and nasal inflammation and improving symptom control.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Montymo AL 75mg/5mg/10mg Tablet SR concurrently with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Montymo AL 75mg/5mg/10mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Montymo AL 75mg/5mg/10mg tablet is likely not safe for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Montymo AL 75mg/5mg/10mg SR tablets may cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Montymo AL 75mg/5mg/10mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Montymo AL 75mg/5mg/10mg SR tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Montymo AL 75mg/5mg/10mg extended-release tablets cautiously. Dosage modification of Montymo AL 75mg/5mg/10mg extended-release tablets may be necessary. Physician consultation is recommended.
What if you forget to take Montymo AL 75mg/5mg/10mg Tablet SR :
Should you forget a Montymo AL 75mg/5mg/10mg SR Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Montymo AL 75mg/5mg/10mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Breathing |
